Patients Question Statins' Safety After FDA's New Label Warnings

A growing number of physicians may find patients questioning the safety of statins following the U.S. Food and Drug Administration's announcement Tuesday that it would require additional safety warnings on the labels of the cholesterol-lowering drugs. Doctors have said that while the benefits of statins outweigh their potential harm, some patients are alarmed by the new announcement. "This news will make the care of my patients more difficult and less effective," said Dr. Richard Honaker, a...Full Story
Commenting on this article is closed.